386 CBP/p300 has firmly been established to act as transcriptional co-activators of androgen receptor (AR)
If youre deciding rather than stacking, the rough guidelines most clinicians use are: BPC-157 alone patients whose primary issue is gut inflammation, inflammatory bowel conditions, NSAID-induced stomach damage, or broader systemic inflammation where the gut is the focal point
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Processed foods, excessive sugar, and refined carbohydrates can promote inflammation and insulin spikes that counteract the peptides benefits
Peptide protocol: Aggressive initial approach, BPC-157 500mcg daily plus Thymosin Beta-4 5mg twice weekly for 4 weeks, then reduce to BPC-157 250mcg daily or Thymosin Beta-4 weekly for additional 4-8 weeks, taper based on healing progress
A slow injection is less painful
